SCHEMBL28969207

SCHEMBL28969207

C[C@@H](CO)c1cccc(OCc2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.59
KMT2A Q03164 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
CYP4F2 P78329 1/20 0.56
CYP4A11 Q02928 1/20 0.56
MAOB P27338 4/20 0.55
MEN1 O00255 1/20 0.55
ALOX5 P09917 1/20 0.55
NR4A2 P43354 1/20 0.51
SGMS2 Q8NHU3 1/20 0.51
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49
RRM1 P23921 1/20 0.49
PTGES O14684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28969175 1.00 BCHE (0.59) BCHEKMT2ASMN1; SMN2CYP4F2CYP4A11
SCHEMBL30312294 1.00 BCHE (0.59) BCHEKMT2ASMN1; SMN2CYP4F2CYP4A11
SCHEMBL24646088 1.00 BCHE (0.59) BCHEKMT2ASMN1; SMN2CYP4F2CYP4A11
SCHEMBL30313797 1.00 BCHE (0.59) BCHEKMT2ASMN1; SMN2CYP4F2CYP4A11
SCHEMBL11159586 0.88 CYP4F2 (0.57) BCHEKMT2ASMN1; SMN2CYP4F2CYP4A11
SCHEMBL28346872 0.86 BCHE (0.60) BCHEKMT2ASMN1; SMN2CYP4F2CYP4A11
SCHEMBL11922929 0.86 BCHE (0.60) BCHEKMT2ASMN1; SMN2CYP4F2CYP4A11
SCHEMBL24646994 0.85 BCHE (0.59) BCHEKMT2ASMN1; SMN2CYP4F2CYP4A11
SCHEMBL23923495 0.84 KMT2A (0.61) BCHEKMT2ASMN1; SMN2CYP4F2CYP4A11
SCHEMBL12221485 0.84 KMT2A (0.61) BCHEKMT2ASMN1; SMN2CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115867536-A GPR40 agonists 卡尔优普公司 2023-03-28 CN disclosed
CN-115667277-A GPR40 agonists 卡尔优普公司 2023-01-31 CN disclosed